Best Available Therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Best Available Therapy, covering 2018-12-11 to 2023-05-23. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF [Phase 3]